Ruthenation of duplex and single-stranded d(CGGCCG) by organometallic anticancer complexes

Chemistry - A European Journal

Volumn 12, Issue 23, 2006, Pages 6151-6165

  Liu, Hong Ke ^a,c   Wang, Fuyi ^a   Parkinson, John A ^b   Bella, Juraj ^a   Sadler, Peter J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c NANJING NORMAL UNIVERSITY   (China)

Author keywords

Antitumor agents; Arenes; DNA; Intercalation; NMR spectroscopy; Ruthenium

Indexed keywords

ANTITUMOR AGENTS; ARENES; BIPHENYL ADDUCTS; INTERCALATION;

DNA; HYDROGEN BONDS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RUTHENIUM; TUMORS;

ORGANOMETALLICS;

ANTINEOPLASTIC AGENT; DNA; LIGAND; ORGANOMETALLIC COMPOUND; POLY[DEOXY(CYTIDYLATE GUANYLATE)]; POLYDEOXYRIBONUCLEOTIDE; RUTHENIUM;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEN BOND; MASS SPECTROMETRY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SENSITIVITY AND SPECIFICITY; STANDARD; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; BINDING SITES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; HYDROGEN BONDING; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; POLYDEOXYRIBONUCLEOTIDES; REFERENCE STANDARDS; RUTHENIUM; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33747186630     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.200600110     Document Type: Article

References (35)

1. R. E. Morris, R. E. Aird, P. D. Murdoch, H. M. Chen, J. Cummings, N.D. Hughes, S. Parsons, A. Parkin, G. Boyd, D.I. Jodrell, P.J. Sadler, J. Med. Chem. 2001, 44, 3616-3621.
2. R. E. Aird, J. Cummings, A. A. Ritchie, M. Muir, R. E. Morris, H. Chen, P. J. Sadler, D. I. Jodrell, Br. J. Cancer 2002, 86, 1652-1657.
3. K.Y. Yan, M. Melchart, A. Habtemariam, P.J. Sadler, Chem. Commun. 2005, 4764-4776.
4. M. Melchart, P.J. Sadler in Bioorganometallics (Ed.: G. Jaouen), Wiley-VCH, Weinheim, 2005, pp. 39-64.
5. O. Novakova, H.M. Chen, O. Vrana, A. Rodger, P.J. Sadler, V. Brabec, Biochemistry 2003, 42, 11 544-11 554.
6. H. M. Chen, J. A. Parkinson, S. Parsons, R. A. Coxall, R. O. Gould, P. J. Sadler, J. Am. Chem. Soc. 2002, 124, 3064-3082.
7. H. M. Chen, J. A. Parkinson, R. E. Morris, P. J. Sadler, J. Am. Chem. Soc. 2003, 125, 173-186.
8. D.B. Zamble, S. J. Lippard, in Cisplatin-Chemistry and Biochemistry of a Leading Anticancer Drug (Ed.: B. Lippert), Wiley-VCH, Weinheim, 1999, pp. 73-110.
9. G. A. Leonard, T. W. Hambley, K. McAuleyhecht, T. Brown, W. N. Hunter, Acta Crystallogr. Sect. D 1993, 49, 458-467.
10. Crystal trials on duplexes ruthenated with complexes 1 or 2 were carried out with sitting drops at 277 or 285 K, by using sodium cacodylate buffers (pH 4.6-7.5) containing magnesium chloride, spermine tetrahydrochloride and 2-methyl-2.4-pentanediol (MPD; 8.3-40%) equilibrated against a reservoir containing 30-100% MPD.
11. S. L. Lam, S. C. F. AuYeung, J. Mol. Biol. 1997, 266, 745-760.
12. J. Vinje, J. A. Parkinson, P. J. Sadler, T. Brown, E. Sletten, Chem. Eur. J. 2003, 9, 1620-1630.
13. J. L. Beck, R. Gupta, T. Urathamakul, N. L. Williamson, M. M. Sheil, J. R. Aldrich-Wright, S. F. Ralph, Chem. Commun. 2003, 626-627.
14. J. A. Parkinson, Y. Chen, P. D. Murdoch, Z. J. Quo, S. J. Berners-Price, T. Brown, P. J. Sadler, Chem. Eur. J. 2000, 6, 3636-3644.
15. D. R. Hare, D. E. Wemmer, S. H. Chou, G. Drobny, B. R. Reid, J. Mol. Biol. 1983, 171, 319-336.
16. F. Y. Wang, J. Bella, J. A. Parkinson, P. J. Sadler, J. Biol. Inorg. Chem. 2005, 10, 147-155.
17. F. Reeder, F. Gonnet, J. Kozelka, J. C. Chottard, Chem. Eur. J. 1996, 2, 1068-1076.
18. H. Baruah, U. Bierbach, Nucleic Acids Res. 2003, 31, 4138-4146.
19. Y. Coppel, J. F. Constant, C. Coulombeau, M. Demeunynck, J. Garcia, J. Lhomme, Biochemistry 1997, 36, 4831-4843.
20. W. D. Wilson, Y. Li, J. M. Veal, in Advances in DNA Sequence Specific Agents (Ed.: L. H. Hurley), New York, 1992, pp. 89-165.
21. J. Lee, V. Guelev, S. Sorey, D. W. Hoffman, B. L. Iverson, J. Am. Chem. Soc. 2004, 126, 14036-14042.
22. X. G. Liang, H. Asanuma, H. Kashida, A. Takasu, T. Sakamoto, G. Kawai, M. Komiyama, J. Am. Chem. Soc. 2003, 125, 16 408-16 415.
23. H. Baruah, U. Bierbach, J. Biol. Inorg. Chem. 2004, 9, 335-344.
24. S. H. Chou, K. H. Chin, F. M. Chen, Proc. Natl. Acad. Sci. USA 2002, 99, 6625-6630.
25. C. Y. Lian, H. Robinson, A. H. J. Wang, J. Am. Chem. Soc. 1996, 118, 8791-8801.
26. C.B. Nielsen, M. Petersen, E.B. Pedersen, P.E. Hansen, U.B. Christensen, Bioconjugate Chem. 2004, 15, 260-269.
27. A. Favier, M. Blackledge, J.-P. Simorre, S. Crouzy, V. Dabouis, A. Gueiffier, D. Marion, J.-C. Debouzy, Biochemistry, 2001, 40, 8717-8726.
28. M. J. Cocco, L. A. Hanakahi, M. D. Huber, N. Maizels, Nucleic Acids Res. 2003, 31, 2944-2951.
29. O. Novakova, J. Kasparkova, V. Bursova, C. Hofr, M. Vojtiskova, H. M. Chen, P. J. Sadler, V. Brabec, Chem. Biol. 2005, 12, 121-129.
30. U.M. Ohndorf, M. A. Rould, Q. He, C. O. Pabo, S. J. Lippard, Nature 1999, 399, 708-712.
31. E. R. Jamieson, S. J. Lippard, Chem. Rev. 1999, 99, 2467-2498.
32. F. Legendre, J.-C. Chottard, in Cisplatin-Chemistry and Biochemistry of a Leading Anticancer Drug (Ed.: B. Lippert), Wiley-VCH, Weinheim, 1999, pp. 223-245.
33. H. M. Chen, J. A. Parkinson, O. Novakova, J. Bella, F. Y. Wang, A. Dawson, R. Gould, S. Parsons, V. Brabec, P. J. Sadler, Proc. Natl. Acad. Sci. USA 2003, 100, 14623-14628.
34. H. Liu, S. J. Berners-Price, F. Wang, J. A. Parkinson, J. Xu, J. Bella, P. J. Sadler, unpublished work.
35. T. L. Hwang, A.J. Shaka, J. Magn. Reson. Ser. A 1995, 112, 275-279.